Kalaris Therapeutics Inc 's

• KLRS's Stock Performance relative to its Competitors

Atara Biotherapeutics Inc Share Performance -2.45% Over The Past 5 Days

Atara Biotherapeutics Inc Profile Atara Biotherapeutics Inc is a biotechnology company that focuses on developing therapies for patients with serious medical conditions. They utilize a personalized medicine approach to create off-the-shelf, allogeneic T-cell immunotherapies. By leveraging their expertise in T-cell immunotherapy and genetic engineering, they aim to provide innovative treatments with the potential for broad patient reach. More about Atara Biotherapeutics Inc 's Market Share

Cryo cell International Inc Share Performance +17.31% This Quarter

Cryo cell International Inc Profile Cryo Cell International Inc's business model revolves around providing innovative services in stem cell banking and preservation. More about Cryo cell International Inc 's Market Share

Celularity Inc Share Performance +69.16% This Quarter

Celularity Inc Profile Celularity is a biotechnology company that focuses on developing and delivering transformative cellular therapies for various diseases. Their business model encompasses acquiring and licensing cellular assets, conducting research and development to advance these therapies, and forming strategic partnerships with healthcare organizations and research institutions to commercialize and distribute their innovative products. Through this model, Celularity aims to address unmet medical needs and provide novel therapies to improve patient outcomes. More about Celularity Inc 's Market Share

Enlivex Therapeutics Ltd Share Performance -42.65% 30 Days

Enlivex Therapeutics Ltd Profile Enlivex Therapeutics Ltd's business model focuses on developing and commercializing novel immune system therapies. More about Enlivex Therapeutics Ltd's Market Share

In8bio Inc Share Performance -55.89% This Year

In8bio Inc Profile In8bio Inc operates as a clinical-stage biotechnology company that focuses on developing transformative therapies for the treatment of cancer and other diseases. The company follows a research and development model centered on leveraging their proprietary platform to identify and optimize novel genetic circuits for targeted cell-based therapies. More about In8bio Inc 's Market Share

Sources: Kalaris Therapeutics Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on: Saturday, August 29, 2026 4:51 AM
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Kalaris Therapeutics Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.